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JOINT diseases a#ect hundreds of millions of
patients throughout the world, causing pain and
disability with a great impact on families and on
society. Osteoarthritis is the most common joint
disease—in terms of years lived with disability it
ranks second for women and fourth for men in the
developed countries, and eighth in the whole
world. Elderly patients are most often involved,
and since the number of individuals over the age
of 50 is expected to double between 1990 and 2020,
the global burden of joint diseases will increase
dramatically.
These conditions include a wide variety of
systemic conditions and many regional and
local articular and periarticular disorders. Better
understanding of the causes and the development
of new and e#ective therapies are likely to di#er
for these two general types of disorder. For the
chronic forms it is important that fully informed
and empowered patients are involved in the choice
of management.
At present, treatment is largely focused on
symptoms, but new studies of basic biology and
pathophysiology will provide opportunities for
improved diagnosis and novel forms of therapy.EPIDEMIOLOGY
Recent work has answered some questions about
the occurrence of diseases and a#ections of joints:
(a) They a#ect people of all ages, and make
major impacts on individuals, societies, and
economic costs in all countries. The increases
in the average age of populations will lead to
more overall disability.
(b) Prevalence varies throughout the world, but
it is not known whether these di#erences have
mainly genetic, lifestyle, or environmental
causes. Exercise, lifestyle, education and
obesity all influence the outcome, but the
precise reasons are uncertain.
(c) Osteoarthritis, the eighth most common cause
of disability in the world, with great costs to251society, has received disproportionately small
investigative e#ort and funding.DIAGNOSIS
The early treatment of joint diseases, particu-
larly of the inflammatory types, is known to
improve outcome. This implies that early diagnosis
is increasingly important to prevent or reduce long
term disability:
(a) Many diseases can now be diagnosed earlier,
for example infective and inflammatory
arthritis, but progress is hampered by insu$-
cient knowledge of the early stages of the
disease, especially osteoarthritis.
(b) Better diagnostic criteria can now distinguish
between over 200 forms of joint a#ections.
(c) Newer imaging techniques such as MRI and
ultrasound, and the use of arthroscopy can
provide more precise early diagnosis of
inflammation and articular damage.
(d) Molecular markers now o#er new insights
into disease mechanisms and heterogeneity.
Further developments will help to diagnose
and monitor disease.
(e) Current diagnostic approaches are not
applied consistently, they vary considerably
throughout the world.PREVENTION
Joint diseases result from interactions between
genes and the environment, which includes activi-
ties, lifestyles, diet, and various toxins. There is
much evidence that incompletely known environ-
mental factors are important both for the onset
and the chronicity of joint diseases. Improved
knowledge of these factors will help to create more
$cient preventive programs. Current examples
include:
(a) Earlier diagnosis and treatment can prevent
death in some life-threatening diseases
such as systemic lupus erythematosus, and
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threatening disorders such as infective
arthritis.
(b) The secondary infection of artificial joint
replacements can be minimized by careful
management. The use of condoms is associ-
ated with a reduction of arthritis associated
with sexually-transmitted diseases. Hygienic
food preparation minimizes Yersinia-induced
arthropathy.
(c) Penicillin prophylaxis can prevent heart dis-
ease after rheumatic fever, but is not uni-
formly available or in regular use world-wide.
(d) Some risk factors have been identified for
certain forms of arthritis. These include
excess weight and joint injuries, whilst some
general lifestyles, diet, and impact activities
are also believed to be associated with higher
risks. It is uncertain whether these factors are
causative or just contributory.
(e) Early diagnosis of many forms of arthritis can
reduce disability through treatment, educa-
tion, and alterations in lifestyle and activities.THERAPY
In the last decade the treatment of some certain
joint diseases has improved significantly:
(a) Current treatments usually centre on the
management of pain and disability, partly
because of our limited understanding of the
actual mechanisms of pain perception.
(b) Patient education, and guided self-
management, have improved outcomes, and
better pharmacotherapeutic reduction of joint
inflammation has reduced damage. New and
more e#ective therapies are being developed
to target specific inflammatory processes.
(c) Mechanical forces play a critical role in
regional and local joint disorders. The general
relationships between the mechanical
environment and tissue adaptation, destruc-
tion and repair are understood, but better
detailed knowledge would make it possible to
remove damaging mechanical conditions and
optimize physical therapies. Some potentially
good biological solutions may be ine#ective at
present because they are overwhelmed by the
mechanical environment.
(d) Large joint replacement is very e$cient for
the most disabled patients, being one of the
most cost-e#ective of all surgical procedures
in any field. Long-term problems of loosening
and wear, however, mean that it must still be
used cautiously in younger patients, evenwhen there are few reasonable and acceptable
alternatives. Alternative treatments are
required, such as osteotomy, or implants with
greater longevity. At present there are very
great variations in the use of joint replace-
ment throughout the world, but inexpensive
replacements for large joints are becoming
available.
(e) New and emerging patient-oriented measure-
ments of outcome will provide far better
assessment, of therapies as well as diseases.
The assessments may need to di#er between
those treated with pharmaceuticals, physio-
therapy, implants, and tissue-restoring
approaches.Future perspectives
The world’s population is ageing substantially,
particularly within the developing world. This and
the increase in prevalence of many of the most
common joint disorders means that the world-wide
social and economic burden from these disorders
will increase substantially in the near future.
Some suggestions can be made to try to reduce this
burden.EPIDEMIOLOGY
We need to know the world-wide burden of joint
disorders including their impact on individuals,
societies, and economic factors. There is great
need for data from developing countries, to
allow the development of the most cost-e#ective
strategies.
Better understanding of genetic and environ-
mental interactions may come from study of the
reasons for the regional variations in prevalence
of various arthropathies.
Study of the changing incidence of joint diseases
as societies undergo changes in living and working
conditions and lifestyles will help to refine and
develop standard outcome assessment tools for
joint disorders focusing not only on disease
parameters but also on functional outcome and
quality of life.DIAGNOSIS
Most joint diseases can be diagnosed by history
and physical examination, but these are not
practised uniformly. New methods will allow
more accurate diagnosis and therefore better
choice and timing of therapy. Better education in
current diagnostic approaches, especially the
widely-available and more inexpensive methods,
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professionals.
We should aim to identify the molecular
events in disease processes to better delineate the
pathophysiological processes. Gene mapping may
ascertain the presence of risk factors in given
individuals.PREVENTION
The identification of environmental as well as
genetic factors contributing to the emergence of
severity of joint diseases will increase our
potential for primary and secondary prevention.
Emphasis should be placed on identifying factors
influencing comorbidity and the psychosocial
consequences of joint disorders.
Prevention of disability will be helped by the
education of patients and healthcare providers,
and more knowledge of situations which have
strong associations with arthropathy, such as
obesity, congenital and developmental disorders of
childhood, and certain types of competitive and
recreational activity.Therapeutic developments
There is promise of major advances in the treat-
ment of a number of joint diseases. Better under-
standing of the immune system will provide a basis
for modulating the immune response in rheuma-
toid arthritis. Some emerging treatments have
reached advanced trials and will be in clinical use
in the next decade. The indications for their use
require clarification and obtaining necessary
funds will need advance planning.
There is a window of opportunity to evaluate
their e#ectiveness set against the very high
current direct and indirect costs of treatment.
Some examples are:
(1) The development of molecules, taken orally,
which are more e#ective at blocking tissue
destruction and promoting tissue repair, and
of less toxic and more e#ective anti-
inflammatory drugs.
(2) The optimal targeting of biologically active
molecules to minimize inflammatory pro-
cesses, reduce or reverse tissue destruction,
and enhance tissue repair.
(3) The establishment of gene therapy for
conditions such as rheumatoid arthritis.
(4) The identification of optimal combinations of
existing therapeutic agents, and the develop-
ment of tissue engineering for connective
tissue repair and replacement.(5) Better methods of assessing the cost-
e#ectiveness of new drugs and devices.Recommendations
(1) We need better understanding of the
peripheral and central mechanisms under-
lying pain, using new technologies such as
PET scanning. Research into the various
physical and psychosocial factors that
contribute to chronic pain will aid its treat-
ment.
(2) Prevent and cure the various forms of
arthritis by defining mechanisms including
genetic predisposition and major environ-
mental triggers, as well as intra- and extracel-
lular signalling mechanisms, including
biomechanical factors.
(3) Promote tissue-engineering techniques to
repair or replace diseased or defective tissues.
(4) Develop delivery approaches and techniques
for bioactive molecules, including gene
therapy.
(5) Develop implant technology to enhance
osseointegration and minimize wear, osteo-
lysis and loosening.
(6) Develop better reconstructive procedures for
elbow, wrist, hand, ankle, and foot.
(7) Identify strategies for the optimal patient
selection and timing of joint replacement.
Implement the use of centres of excellence
for implant revision operations and the less
common implants.
(8) Assess new technology by multinational trials
and registries using patient-oriented outcome
tools.
(9) Develop new aids and devices for disabled
patients.
(10) Develop cost-e#ective training programs for
muscle strength and co-ordination in the
elderly to enhance joint function and bone
strength.
(11) Support world-wide comparative epidemio-
logical studies.Specific goals
The main goal is the delivery of the appropriate
treatment to individual patients, chosen from the
many available. This needs exploring the optimum
models for healthcare delivery, which may well
vary in di#erent cultural and economic environ-
ments. In chronic disorders, the informed and
empowered patient must be a critical part of any
therapy.
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application are needed to develop cost-
e#ective patient care.
(2) Develop new therapeutic strategies to
modulate and ultimately inhibit disease
progression.
(3) Decrease pain and improve function through
more e#ective multidisciplinary use of educa-
tion and current treatments. Emphasis on
patient self-management will improve com-
pliance and control of disease.
(4) Better education of healthcare professionals,
patients, the community, and policy-makers
should use the current knowledge base with
new methods of information transfer such asthe Internet. Specialists in communication
should help to maximize the transfer of knowl-
edge and new research information; patient-
advocate groups should be included in the
communication network.Final conclusion
Unless early investment is made in increased
research and education to decrease the global
burden of joint disease, the dynamics of these
conditions in the ageing population will generate
an avalanche of costs, disability and su#ering in
the future.
